Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[The authors present here the clinical, anatomic, and endocrine-metabolic studies of three patients, with a view toward careful delineation of the syndrome and further characterization of the metabolic defect.The most striking and consistent metabolic derangements present in all of these patients were fasting hypoglycemia (less than 20 mg/dL), postprandial hyperglycemia (more than 250 mg/dL), marked hyperinsulinemia (more than 2000 ?U/mL), and severe insulin resistance (less than a 20 percent decrease in blood sugar with 0.3 to 1.0 U/kg of regular insulin IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP186106.RAm6H5YsD0FcUcYnWbCjFDmC8zaGE2hx23aUuAdoXa0kg130_assertion description "[The authors present here the clinical, anatomic, and endocrine-metabolic studies of three patients, with a view toward careful delineation of the syndrome and further characterization of the metabolic defect.The most striking and consistent metabolic derangements present in all of these patients were fasting hypoglycemia (less than 20 mg/dL), postprandial hyperglycemia (more than 250 mg/dL), marked hyperinsulinemia (more than 2000 ?U/mL), and severe insulin resistance (less than a 20 percent decrease in blood sugar with 0.3 to 1.0 U/kg of regular insulin IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP186106.RAm6H5YsD0FcUcYnWbCjFDmC8zaGE2hx23aUuAdoXa0kg130_provenance.
• NP163321.RAx-T8fZlUGDCr6At6lAnThQ_rKxSH9lr_kHpmOWBwbi0130_assertion description "[The authors present here the clinical, anatomic, and endocrine-metabolic studies of three patients, with a view toward careful delineation of the syndrome and further characterization of the metabolic defect.The most striking and consistent metabolic derangements present in all of these patients were fasting hypoglycemia (less than 20 mg/dL), postprandial hyperglycemia (more than 250 mg/dL), marked hyperinsulinemia (more than 2000 ?U/mL), and severe insulin resistance (less than a 20 percent decrease in blood sugar with 0.3 to 1.0 U/kg of regular insulin IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163321.RAx-T8fZlUGDCr6At6lAnThQ_rKxSH9lr_kHpmOWBwbi0130_provenance.
• NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_assertion description "[The authors present here the clinical, anatomic, and endocrine-metabolic studies of three patients, with a view toward careful delineation of the syndrome and further characterization of the metabolic defect.The most striking and consistent metabolic derangements present in all of these patients were fasting hypoglycemia (less than 20 mg/dL), postprandial hyperglycemia (more than 250 mg/dL), marked hyperinsulinemia (more than 2000 ?U/mL), and severe insulin resistance (less than a 20 percent decrease in blood sugar with 0.3 to 1.0 U/kg of regular insulin IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512177.RATJskCrIlzRk8repwH_2XTeunu-ta8hugHtn1Kd8BFyE130_provenance.
• NP1007855.RAYfELa4pxivABnqd_XQ44mnOwRfSS-gKazVAcGMxdKsw130_assertion description "[The authors present here the clinical, anatomic, and endocrine-metabolic studies of three patients, with a view toward careful delineation of the syndrome and further characterization of the metabolic defect.The most striking and consistent metabolic derangements present in all of these patients were fasting hypoglycemia (less than 20 mg/dL), postprandial hyperglycemia (more than 250 mg/dL), marked hyperinsulinemia (more than 2000 ?U/mL), and severe insulin resistance (less than a 20 percent decrease in blood sugar with 0.3 to 1.0 U/kg of regular insulin IV).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1007855.RAYfELa4pxivABnqd_XQ44mnOwRfSS-gKazVAcGMxdKsw130_provenance.